A01K 2267/0318
Animal model for neurodegenerative disease
Official title: Animal model for neurodegenerative disease, e.g. non- Alzheimer's
A01K2267/0318 (Animal model for neurodegenerative disease) appears on 251 US grants and 437 published applications in this corpus.
Search patents in A01K- Granted patents
- 251
- Published applications
- 437
- Assignees
- 278
- Inventors
- 891
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 10 | 0 |
| 1998 | 13 | 0 |
| 1999 | 10 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 0 |
| 2002 | 5 | 18 |
| 2003 | 17 | 25 |
| 2004 | 5 | 13 |
| 2005 | 5 | 13 |
| 2006 | 4 | 11 |
| 2007 | 11 | 17 |
| 2008 | 7 | 15 |
| 2009 | 5 | 11 |
| 2010 | 4 | 12 |
| 2011 | 9 | 19 |
| 2012 | 3 | 12 |
| 2013 | 7 | 6 |
| 2014 | 6 | 9 |
| 2015 | 3 | 10 |
| 2016 | 6 | 17 |
| 2017 | 7 | 15 |
| 2018 | 9 | 14 |
| 2019 | 7 | 20 |
| 2020 | 9 | 26 |
| 2021 | 6 | 24 |
| 2022 | 8 | 30 |
| 2023 | 15 | 31 |
| 2024 | 13 | 35 |
| 2025 | 17 | 21 |
| 2026 | 15 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating mitochondrial disorders1 Sep 2026US 12,723,062 B2The Regents of the University of California
- Neurodegenerative and amyotrophic model animal25 Aug 2026US 12,714,076 B2Tokyo Metropolitan Institute of Medical Science
- Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder7 Jul 2026US 12,673,119 B2University of Rochester
- Humanized chimeras for the prospective assessment of cell addition and replacement therapies9 Jun 2026US 12,648,547 B2University of Copenhagen
- Compositions useful in treatment of spinal muscular atrophy28 Apr 2026US 12,612,647 B2The Trustees of the University of Pennsylvania
- Nucleic acid vector comprising a coding sequence of the epm2a gene13 Aug 2026US 2026/0234661 A1
- Treatment of krabbe disease with umbilical cord blood transplantation (ucbt) and increased galactocerebrosidase (galc) expression6 Aug 2026US 2026/0224639 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods and compositions for modulating gene expression6 Aug 2026US 2026/0226464 A1Flagship Pioneering Innovations V, Inc.
- Humanized chimeras for the prospective assessment of cell addition and replacement therapies16 Jul 2026US 2026/0198466 A1University of Copenhagen
- Compositions for treating friedreich's ataxia2 Jul 2026US 2026/0183422 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Methods for monitoring cellular processing of .beta.-amyloid precursor protein167US 5,441,870 AAthena Neurosciences, Inc. · 1995
- Transgenic animals harboring APP allele having swedish mutation142US 5,612,486 AAthena Neurosciences, Inc. · 1997
- Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease122US 5,877,399 ARegents of the University of Minnesota · 1999
- Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP114US 5,721,130 AAthena Neurosciences, Inc. · 1998
- Expression of human interleukin-1.beta. in a transgenic animal103US 5,824,837 AMerck & Co., Inc. · 1998